Skip to content
Screener

UroGen Pharma URGN Price / book

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.3×-0.2×
Pfizer logo
PfizerPFE
1.8×+0.2×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.2×+2.5×
Merck & Co. logo
Merck & Co.MRK
7.6×+3.5×
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
4×+1.7×
Tyra Biosciences, Inc. logo
Tyra Biosciences, Inc.TYRA
5.3×+3.8×

Other financials

Income statement

See full
Revenue$72.5M+199%
Net income-$14.4M+71.3%

Balance sheet

See full
Cash & equivalents$79.1M-14.8%
Total debt$197.5M+55.0%
Total equity-$132.4M-41.8%
Total assets$252.6M+21.0%

Cash flow

See full
Operating cash flow-$33.0M+17.1%
CapEx$60.0K-57.4%
Free cash flow-$33.1M+17.3%

Valuation

See full
Market cap$2.22B+140%
Enterprise value$2.34B+144%
P/S11.8×+2.0×

Profitability

See full
Gross margin89.7%—
Operating margin-329.7%—
Net margin-51.7%-21.0pp
FCF margin-84.3%-22.2pp

Returns & leverage

See full
Return on equity-211.6%—
Debt / equity4.8×—
Current ratio3.8×-0.3×

Where this comes from

Calculated from UroGen Pharma’s reported figures.

market cap/total stockholders equity=20.5×

Based on the most recent quarter.

The source filing: UroGen Pharma’s 10-Q, filed November 6, 2024. Open the filing →

Filed
Nov 6, 2024
Fiscal quarter
Q3 FY2024
Calendar quarter
Q3 2024
Accession
0001437749-24-033454

FAQ

What is UroGen Pharma's price / book?
UroGen Pharma (URGN) reported price / book of 20.5× in Q3 2024.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about UroGen Pharma's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude